Arrow International's R&D capabilities and complementary business model enticed Teleflex to buy the critical care device maker for $2 billion as part of an ongoing transformation of its device business, the firms said July 23 (see chart: "1Teleflex-Arrow Deal Basics")
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.
SS Innovations reported its first SSi Mantra 3 robotic cardiac surgery in South America as it prepares to file for US FDA de novo clearance and a CE mark. The firm aims to challenge Intuitive Surgical with a lower-cost, flexible system targeting US and European markets.
Innovative Healthcare is asking for a permanent injunction against Johnson & Johnson subsidiary Biosense Webster after winning a $442 million antitrust verdict. The injunction aims to prevent continued anticompetitive practices in the electrophysiology catheter market.
